Let’s See... Lyrica goes away, Chantix is more of a Cluster 2 drug, Eucrisa and Xtandi are only Cluster 1 because of contracts. Now the new pain drug isn’t coming. What in the heck are we going to be selling? How is Eucrisa doing? My counterpart sells it and she says it’s doing very well. True? What about in Derm? I’ve never seen our portfolio this empty.
I’m interviewing with Pfizer. The new pain drug isn’t coming? I thought it was in phase 3. Do you have any other info on this? Thank you!
Folks sorry to say there's nothing there, How many times do we have to go thru this same routine and not learn? Promotion of Lyrica will stop in summer (always 6 months prior). Viagra is gone. Not enough money in Chantix or Flector or Eucrisa with nothing new on the horizon. Calls will be made around October whats left will reorg starting "fresh" in January 2019. Goes round and round. Sorry but find a new division soon.
Sad but true. How long until we are told to control the controllables? I’m hoping Pfizer comes off some cash and buys me something to sell.
Ok everyone pump the brakes! Has everyone forgotten about tanezumab? It’s been fast tracked and will be ready to roll soon.
will that just be for specialists? if so, that doesn't help the majority of cluster 1 calling on primary care
Please correct me if I’m wrong, but I believe it’s an injection that will likely be done in a specialists office...not much, if any, primary care.
Hope so. Give me my severance. Can’t wait to get out of this shitshow. Tikal bunch of morons too to bottom.
